| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.36 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |